BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36379272)

  • 1. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice.
    Nayeri T; Sarvi S; Fasihi-Ramandi M; Valadan R; Asgarian-Omran H; Ajami A; Khalilian A; Hosseininejad Z; Dodangeh S; Javidnia J; Daryani A
    Exp Parasitol; 2023 Jan; 244():108427. PubMed ID: 36379272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice.
    Dodangeh S; Fasihi-Ramandi M; Daryani A; Valadan R; Asgarian-Omran H; Hosseininejad Z; Nayeri Chegeni T; Pagheh AS; Javidnia J; Sarvi S
    Microb Pathog; 2021 Apr; 153():104764. PubMed ID: 33548480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity induced with a DNA vaccine encoding B- and T-cells multi-epitope SAG1, ROP16, MIC4, GRA12, M2AP, and multi-epitope ROP8 against acute and chronic toxoplasmosis in BALB/c mice.
    Ghaffari AD; Dalimi A; Ghaffarifar F; Pirestani M
    Exp Parasitol; 2022 Nov; 242():108385. PubMed ID: 36162598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
    Meng M; He S; Zhao G; Bai Y; Zhou H; Cong H; Lu G; Zhao Q; Zhu XQ
    Parasit Vectors; 2012 Nov; 5():273. PubMed ID: 23181694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
    Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
    Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory chitosan nanoparticles for Toxoplasma gondii infection: Novel application of chitosan in complex propranolol-hydrochloride as an adjuvant in vaccine delivery.
    Khorshidvand Z; Shirian S; Amiri H; Zamani A; Maghsood AH
    Int J Biol Macromol; 2023 Dec; 253(Pt 8):127228. PubMed ID: 37839605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model.
    Khorshidvand Z; Khosravi A; Mahboobian MM; Larki-Harchegani A; Fallah M; Maghsood AH
    Int J Biol Macromol; 2022 May; 208():962-972. PubMed ID: 35346684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Immune Responses to a DNA Vaccine Encoding
    Sun HC; Huang J; Fu Y; Hao LL; Liu X; Shi TY
    Front Cell Infect Microbiol; 2021; 11():787635. PubMed ID: 34976863
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii.
    Cong H; Zhang M; Xin Q; Wang Z; Li Y; Zhao Q; Zhou H; He S
    Parasit Vectors; 2013 Mar; 6():63. PubMed ID: 23497561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.
    Khodadadi M; Ghaffarifar F; Dalimi A; Ahmadpour E
    Acta Trop; 2021 Apr; 216():105836. PubMed ID: 33485872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.
    Lu G; Zhou A; Meng M; Wang L; Han Y; Guo J; Zhou H; Cong H; Zhao Q; Zhu XQ; He S
    BMC Infect Dis; 2014 Dec; 14():3862. PubMed ID: 25527277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of Immune Responses Elicited by Adjuvanted Tachyzoite Lysate Vaccines Developed from Two Different Toxoplasma gondii Strains Isolated in Turkey].
    Polat C; Gülçe İz S; Döşkaya M; Can H; Caner A; Değirmenci A; Balcan E; Gürüz Y
    Mikrobiyol Bul; 2013 Jan; 47(1):122-34. PubMed ID: 23390909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological evaluation of a novel multi-antigenic DNA vaccine encoding SAG1, SAG3, MIC4, GRA5, GRA7, AMA1and BAG1 against Toxoplasma gondii in BALB/c mice.
    Alijani M; Saffar B; Yosefi Darani H; Mahzounieh M; Fasihi-Ramandi M; Shakshi-Niaei M; Soltani S; Ghaemi A; Shirian S
    Exp Parasitol; 2023 Jan; 244():108409. PubMed ID: 36403800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.
    Han Y; Zhou A; Lu G; Zhao G; Wang L; Guo J; Song P; Zhou J; Zhou H; Cong H; He S
    BMC Infect Dis; 2017 Jan; 17(1):59. PubMed ID: 28077075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.